Press releases

and Washington, D.C. (October 20, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced nine-month sub-population data from its TAXUS V clinical trial that further supports the...

and Washington, D.C. (October 19, 2005) -- Boston Scientific Corporation (NYSE: BSX) was recognized by physicians as a leader in the pursuit of evidence-based medicine through increased use of...

and Washington, D.C. (October 18, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced follow-up data supporting excellent long-term safety and efficacy from four of its TAXUS...

(October, 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) today presented data from its BEACH clinical trial, which was designed to evaluate the benefits of carotid artery stenting (CAS) in...

, and Washington, D.C. (October 17, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the combined results from the BLAZE and BLAZE II registries showing that its...

(October 14, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced financial results for its third quarter ended September 30, 2005 and provided revised revenue and earnings-per-share...

(October 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) today introduced a new program that will offer participating medical centers in the United States a TAXUS® Express2™ stent system...

(October 13, 2005) -- Boston Scientific Corporation (NYSE: BSX) announced today that a Dutch appeals court yesterday overturned a lower court ruling and reinstated an injunction against the...

(October 10, 2005) -- Boston Scientific Corporation (NYSE: BSX) today announced the schedule of the Company

(October 7, 2005) -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results for the third quarter ended September 30, 2005 on Friday, October 14,...